About Yither Biotech
Caring for life, sharing health and making high quality vaccines.
Yither biotech (Shanghai) Co., Ltd (Yither Bio) is located in Zhangjiang Hi-Tech Park, Pudong, Shanghai, and is a wholly-owned subsidiary of Ab&b Bio-Tech CO., LTD.JS . As an innovative bio-enterprise, Yither Biotech's mission is to develop new human vaccines to meet the demand of China and global markets.
News Center
The Recombinant Herpes Zoster Vaccine (CHO Cell) has completed the pre-Phase Ⅲ Meeting
Recently, the recombinant herpes zoster vaccine (CHO cells) jointly developed by Ab&B Bio-Tech CO.,LTD.JS and Yither Biotech Co., Ltd has obtained positive safety and immunogenicity data in its Phase Ⅰ/Ⅱ clinical trials, and the CDE pre-Phase Ⅲ Meeting has been successfully completed, which supports the launch of Phase Ⅲ clinical trials. This is another positive progress following the initiation of the Phase Ⅰ/Ⅱ clinical trials of the recombinant herpes zoster vaccine (CHO cells) project.
Recently, the IND application for a Class 1 new drug, the "Monkeypox mRNA vaccine," jointly submitted by Ab&B Bio-Tech CO.,LTD.JS (Ab&B Bio) and its subsidiary Yither Biotech CO., Ltd (Yither Bio), was approved by the Center for Drug Evaluation (CDE) of the China National Medical Products Administration.
Recently, the IND application for a Class 1 new drug— "Respiratory Syncytial Virus mRNA Vaccine" —jointly submitted by Ab&B Bio-Tech Co. Ltd. JS (Ab&B Bio) and its subsidiary Yither Biotech (Shanghai) Co., Ltd. (Yither Bio) was approved by the Center for Drug Evaluation (CDE) of the China National Medical Products Administration.
Need more help?
Yither Biotech is striving for and committed to producing innovative and quality vaccines to contribute to the development of China’s biomedical industry and the wellness of Chinese and people around the world.
CONTACT
E-Mail:
yue.peng@yitherbiotech.com
Hotline:
+86-021-61639751
Address:
No. 5, Lane 1690, zhangheng Road, Pudong New Area, Shanghai